New pathophysiological insights explain life-saving benefits of perindopril in coronary artery disease patients.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017023:Coronary Angiography; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000401:mortality*; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000401:mortality* / Q000517:prevention & control; D020913:Perindopril / Q000627:therapeutic use*; D011379:Prognosis; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D016019:Survival Analysis; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D003692:Delayed-Action Preparations; D020913:Perindopril